rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Elanco Animal Health Incorporated

ELAN · NYSE

Health CarePharmaceuticalsNot moving yet

ELAN stood above a rising 150-day average in 37 of the last 52 weekly readings, and has been out of that trend for the last 8 weeks. It is 4.4% below that average now. Pharmaceuticals: 37% of its 74 stocks in an uptrend (−1 points in four weeks); Health Care: 27% (−6 points in four weeks).

Statistics

Last close, 22 Oct 2026
22.69 +0.62%
52-week range
—
Volume
4.45M
Average volume (50 days)
—
Relative volume
—
Rotation
Not moving yet
Weeks in an uptrend
out for 8
Industry in uptrend
37% -1 in 4 wk
Insider buys, 12 months
$4.3M
Insider sales, 12 months
$100K
Officials’ trades on record
23
Institutions holding
486 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 37 of 52 weeks.

24 Apr – 23 Oct
25%36%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Price and volume

$21.55$22.61$23.6711 Sep23 Sep2 Oct13 Oct22 Oct
close

Daily bars to 22 Oct 2026: 29 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$2.8MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

23 disclosed lines: House 21, Senate 2, executive 0; 8 people.

WhoDidAmountTraded
Val T. Hoyle House: U.S. House ClerkOR04soldspouse$1k–$15k23 Sep 2025filed 10 Oct 2025
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k6 Mar 2023filed 17 Apr 2023
Dan Sullivan Senate: U.S. Senate eFDSenatorsoldjoint$1k–$15k30 Nov 2022filed 26 Jul 2023
Susie Lee House: U.S. House ClerkNV03soldjoint$1k–$15k30 Nov 2022filed 29 Dec 2022
Dan Sullivan Senate: U.S. Senate eFDSenatorsoldjoint$1k–$15k30 Nov 2022filed 21 Dec 2022
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k21 Jun 2021filed 13 Jul 2021
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k10 Jun 2021filed 13 Jul 2021
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k21 Dec 2020filed 11 Jan 2021
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k6 Nov 2020filed 8 Dec 2020
Katherine M. Clark House: U.S. House ClerkMA05soldspouse$1k–$15k5 Nov 2020filed 28 Dec 2020
Katherine M. Clark House: U.S. House ClerkMA05soldspouse$1k–$15k5 Nov 2020filed 28 Dec 2020
Katherine M. Clark House: U.S. House ClerkMA05boughtspouse$1k–$15k22 Oct 2020filed 3 Dec 2020

Insiders

Buy orders, 12 months11
Sale orders, 12 months1
Buyers · sellers7 · 1
WhoDidSharesTraded
Timothy J. BettingtonSEE REMARKSsold4,350at $23.0015 Oct 2026filed 19 Oct 2026
Lawrence Erik KurziusDirectorbought40,000at $23.4020 Aug 2026filed 21 Aug 2026
Shiv O'NeillGC AND CORP SECbought3,998at $23.5818 Aug 2026filed 18 Aug 2026
Michael J. HarringtonDirectorbought5,000at $21.8212 Aug 2026filed 13 Aug 2026
Paul HerendeenDirectorbought10,000at $23.697 Aug 2026filed 10 Aug 2026
Robert M. VanhimbergenEVP and CFObought4,200at $23.087 Aug 2026filed 10 Aug 2026
Jeffrey N. SimmonsPRESIDENT, CEO AND DIRECTORbought4,971at $20.0915 May 2026filed 19 May 2026
Rajeev A. ModiSEE REMARKSbought4,911at $20.3515 May 2026filed 19 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders486+6 on the quarter
New · exited78 · 73
Reported value$13.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Dodge & Coxreduced · filed 13 Aug 202667,397,025$1.7B-1,547,075−2.2%
FMR LLCadded · filed 13 Aug 202656,948,819$1.4B+6,023,453+11.8%
BlackRock, Inc.added · filed 7 Aug 202648,849,973$1.2B+1,227,343+2.6%
PRIMECAP MANAGEMENT COreduced · filed 14 Aug 202645,445,012$1.1B-395,944−0.9%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 202625,417,271$625.5M+890,136+3.6%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202622,672,312$558.0M+34,955+0.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202622,607,532$556.4M+271,408+1.2%
STATE STREET CORPadded · filed 7 Aug 202616,063,046$395.3M+726,567+4.7%
Winslow Capital Management, LLCreduced · filed 13 Aug 202613,511,127$332.5M-103,228−0.8%
Black Creek Investment Management Inc.added · filed 12 Aug 202613,046,420$321.1M+2,552,571+24.3%
31 Mar 2023 – 30 Jun 2026
310395479Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jeffrey N. Simmons Company insiderPRESIDENT, CEO AND DIRECTOR · last 16 Oct 20269 · 0
Rajeev A. Modi Company insiderSEE REMARKS · last 16 Oct 20263 · 0
Robert M. VanHimbergen Company insiderEVP and CFO · last 16 Oct 20262 · 0
Timothy J. Bettington Company insiderSEE REMARKS · last 15 Oct 20260 · 1
Kapila K. Anand Company insiderDirector · last 30 Sep 20263 · 0
Lawrence Erik Kurzius Company insiderDirector · last 20 Aug 20265 · 0
Shiv O'Neill Company insiderGC AND CORP SEC · last 18 Aug 20261 · 0
Michael J. Harrington Company insiderDirector · last 12 Aug 20267 · 0
Paul Herendeen Company insiderDirector · last 7 Aug 20262 · 0
David S. Kinard Company insiderSEE REMARKS · last 1 Jul 20262 · 0
Art A. Garcia Company insiderDirector · last 21 May 20262 · 0
Deborah Turner Kochevar Company insiderDirector · last 21 May 20261 · 0

Same industry

ABBV AbbVieLeading+19%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202555.0%
Free cash flow marginFY 2025 · to 31 Dec 20256.0%
Debt to equityFY 2025 · to 31 Dec 20250.57×
Research spendFY 2025 · to 31 Dec 20257.8%
Share count trendFY 2025 · to 19 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$545.0M
Free cash flowFY 2025 · to 31 Dec 2025$284.0M

Analyst forecasts

No analyst forecasts yet.